254 related articles for article (PubMed ID: 19395651)
1. Caveolin-1 (P132L), a common breast cancer mutation, confers mammary cell invasiveness and defines a novel stem cell/metastasis-associated gene signature.
Bonuccelli G; Casimiro MC; Sotgia F; Wang C; Liu M; Katiyar S; Zhou J; Dew E; Capozza F; Daumer KM; Minetti C; Milliman JN; Alpy F; Rio MC; Tomasetto C; Mercier I; Flomenberg N; Frank PG; Pestell RG; Lisanti MP
Am J Pathol; 2009 May; 174(5):1650-62. PubMed ID: 19395651
[TBL] [Abstract][Full Text] [Related]
2. Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion.
Williams TM; Medina F; Badano I; Hazan RB; Hutchinson J; Muller WJ; Chopra NG; Scherer PE; Pestell RG; Lisanti MP
J Biol Chem; 2004 Dec; 279(49):51630-46. PubMed ID: 15355971
[TBL] [Abstract][Full Text] [Related]
3. Caveolin-1 mutations in human breast cancer: functional association with estrogen receptor alpha-positive status.
Li T; Sotgia F; Vuolo MA; Li M; Yang WC; Pestell RG; Sparano JA; Lisanti MP
Am J Pathol; 2006 Jun; 168(6):1998-2013. PubMed ID: 16723714
[TBL] [Abstract][Full Text] [Related]
4. Caveolin-1 mutations (P132L and null) and the pathogenesis of breast cancer: caveolin-1 (P132L) behaves in a dominant-negative manner and caveolin-1 (-/-) null mice show mammary epithelial cell hyperplasia.
Lee H; Park DS; Razani B; Russell RG; Pestell RG; Lisanti MP
Am J Pathol; 2002 Oct; 161(4):1357-69. PubMed ID: 12368209
[TBL] [Abstract][Full Text] [Related]
5. Genetic ablation of caveolin-1 drives estrogen-hypersensitivity and the development of DCIS-like mammary lesions.
Mercier I; Casimiro MC; Zhou J; Wang C; Plymire C; Bryant KG; Daumer KM; Sotgia F; Bonuccelli G; Witkiewicz AK; Lin J; Tran TH; Milliman J; Frank PG; Jasmin JF; Rui H; Pestell RG; Lisanti MP
Am J Pathol; 2009 Apr; 174(4):1172-90. PubMed ID: 19342371
[TBL] [Abstract][Full Text] [Related]
6. Using Caveolin-1 epithelial immunostaining patterns to stratify human breast cancer patients and predict the Caveolin-1 (P132L) mutation.
Mercier I; Bryant KG; Sotgia F; Bonuccelli G; Witkiewicz AK; Dasgupta A; Jasmin JF; Pestell RG; Lisanti MP
Cell Cycle; 2009 May; 8(9):1396-401. PubMed ID: 19342880
[TBL] [Abstract][Full Text] [Related]
7. RNA inference-mediated caveolin-1 down-regulation decrease estrogen receptor alpha (ERα) signaling in human mammary epithelial cells.
Wang X; Feng S; Zhang H; Wang Y; Cui Y; Wang Z; Liu J; Zou W
Mol Biol Rep; 2011 Feb; 38(2):761-8. PubMed ID: 20411337
[TBL] [Abstract][Full Text] [Related]
8. Role of caveolin-1 as a biomarker for radiation resistance and tumor aggression in lung cancer.
Leiser D; Samanta S; Eley J; Strauss J; Creed M; Kingsbury T; Staats PN; Bhandary B; Chen M; Dukic T; Roy S; Mahmood J; Vujaskovic Z; Shukla HD
PLoS One; 2021; 16(11):e0258951. PubMed ID: 34762666
[TBL] [Abstract][Full Text] [Related]
9. Caveolin-1, mammary stem cells, and estrogen-dependent breast cancers.
Sotgia F; Rui H; Bonuccelli G; Mercier I; Pestell RG; Lisanti MP
Cancer Res; 2006 Nov; 66(22):10647-51. PubMed ID: 17108100
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical and molecular analysis of caveolin-1 expression in canine mammary tumors.
Zuccari DA; Castro R; Gavioli AF; Mancini UM; Frade CS; Leonel C
Genet Mol Res; 2012 Jan; 11(1):153-65. PubMed ID: 22370882
[TBL] [Abstract][Full Text] [Related]
11. Regulation of Cripto-1 signaling and biological activity by caveolin-1 in mammary epithelial cells.
Bianco C; Strizzi L; Mancino M; Watanabe K; Gonzales M; Hamada S; Raafat A; Sahlah L; Chang C; Sotgia F; Normanno N; Lisanti M; Salomon DS
Am J Pathol; 2008 Feb; 172(2):345-57. PubMed ID: 18202186
[TBL] [Abstract][Full Text] [Related]
12. Expression of caveolin-1 is correlated with lung adenocarcinoma proliferation, migration, and invasion.
Luan TY; Zhu TN; Cui YJ; Zhang G; Song XJ; Gao DM; Zhang YM; Zhao QL; Liu S; Su TY; Zhao RJ
Med Oncol; 2015 Jul; 32(7):207. PubMed ID: 26094077
[TBL] [Abstract][Full Text] [Related]
13. Stromal and epithelial caveolin-1 both confer a protective effect against mammary hyperplasia and tumorigenesis: Caveolin-1 antagonizes cyclin D1 function in mammary epithelial cells.
Williams TM; Sotgia F; Lee H; Hassan G; Di Vizio D; Bonuccelli G; Capozza F; Mercier I; Rui H; Pestell RG; Lisanti MP
Am J Pathol; 2006 Nov; 169(5):1784-801. PubMed ID: 17071600
[TBL] [Abstract][Full Text] [Related]
14. Cooperative signaling between Wnt1 and integrin-linked kinase induces accelerated breast tumor development.
Oloumi A; Maidan M; Lock FE; Tearle H; McKinney S; Muller WJ; Aparicio SA; Dedhar S
Breast Cancer Res; 2010; 12(3):R38. PubMed ID: 20565980
[TBL] [Abstract][Full Text] [Related]
15. Galectin-3- and phospho-caveolin-1-dependent outside-in integrin signaling mediates the EGF motogenic response in mammary cancer cells.
Boscher C; Nabi IR
Mol Biol Cell; 2013 Jul; 24(13):2134-45. PubMed ID: 23657817
[TBL] [Abstract][Full Text] [Related]
16. Caveolin-1 tumor-promoting role in human melanoma.
Felicetti F; Parolini I; Bottero L; Fecchi K; Errico MC; Raggi C; Biffoni M; Spadaro F; Lisanti MP; Sargiacomo M; Carè A
Int J Cancer; 2009 Oct; 125(7):1514-22. PubMed ID: 19521982
[TBL] [Abstract][Full Text] [Related]
17. Caveolin-1 mutants P132L and Y14F are dominant negative regulators of invasion, migration and aggregation in H1299 lung cancer cells.
Shatz M; Lustig G; Reich R; Liscovitch M
Exp Cell Res; 2010 Jun; 316(10):1748-62. PubMed ID: 20153318
[TBL] [Abstract][Full Text] [Related]
18. Mammary tumor formation and metastasis evoked by a HER2 splice variant.
Alajati A; Sausgruber N; Aceto N; Duss S; Sarret S; Voshol H; Bonenfant D; Bentires-Alj M
Cancer Res; 2013 Sep; 73(17):5320-7. PubMed ID: 23867476
[TBL] [Abstract][Full Text] [Related]
19. Caveolin-1 in diagnosis and prognosis of canine mammary tumours: comparison of evaluation systems.
Pereira PD; Lopes CC; Matos AJ; Cortez PP; Gärtner F; Medeiros R; Lopes C
J Comp Pathol; 2010; 143(2-3):87-93. PubMed ID: 20153868
[TBL] [Abstract][Full Text] [Related]
20. Loss of caveolin-1 gene expression accelerates the development of dysplastic mammary lesions in tumor-prone transgenic mice.
Williams TM; Cheung MW; Park DS; Razani B; Cohen AW; Muller WJ; Di Vizio D; Chopra NG; Pestell RG; Lisanti MP
Mol Biol Cell; 2003 Mar; 14(3):1027-42. PubMed ID: 12631721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
